Your new experience awaits. Try the new design now and help us make it even better

RETRACTION article

Front. Genet., 14 January 2026

Sec. Cancer Genetics and Oncogenomics

Volume 17 - 2026 | https://doi.org/10.3389/fgene.2026.1781969

Retraction: Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients

This article is a retraction of:

  1. RETRACTED: Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients

by Jiao M, Sun W, Li L, Li C, Zhou J, Li Q and Duan L (2022). Front. Genet. 13:878123. doi: 10.3389/fgene.2022.878123

The journal retracts the 28 September 2022 article cited above.

Following concerns regarding the originality of the article, an investigation was conducted in accordance with Frontiers’ policies. It was found that the complaint was valid and that the article should be retracted, because of an unacceptable level of similarity to a preprint article published on Research Square by different authors:

Hao, J., Cao, Y., Gu, X., Ma, M., Wang, W., Xue, Y., An, R. (2021). Upregulated SPOCK2 Predicts a Worse Overall Survival and Correlates with Abundance of Tumor Infiltrating Immune Cells for High-Grade Serous Ovarian Cancer. Research Square [Preprint]. Available at: https://doi.org/10.21203/rs.3.rs-885744/v1 (Accessed January 6, 2026).

This retraction was approved by the Chief Editors of Genetics and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.

Frontiers would like to thank the concerned reader who contacted us regarding the published article.

Citation: Frontiers Editorial Office (2026) Retraction: Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients. Front. Genet. 17:1781969. doi: 10.3389/fgene.2026.1781969

Received: 06 January 2026; Accepted: 06 January 2026;
Published: 14 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.